about
Cyclin dependent kinase inhibitor 2AArginase 2Pro-apoptotic WT1 regulatorEukaryotic translation elongation factor 1 epsilon 1Sirtuin 1Killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4High mobility group AT-hook 1Yippee like 3Cyclic GMP-AMP synthasePRKC, apoptosis, WT1, regulatorSirtuin 1Kirsten rat sarcoma viral oncogene homologTumor suppressor ARFHigh mobility group AT-hook 1BHigh mobility group AT-hook 2Arginase type IIEukaryotic translation elongation factor 1 epsilon 1Yippee like 3Cyclic GMP-AMP synthaseKRAS proto-oncogene, GTPaseHigh mobility group AT-hook 1Eukaryotic translation elongation factor 1 epsilon 1High mobility group AT-hook 2Yippee-like 3Histocompatibility 2, M region locus 3Major histocompatibility complex, class I, GKRAS proto-oncogene, GTPaseCyclin dependent kinase inhibitor 2AArginase 2Cyclic GMP-AMP synthaseHigh mobility group AT-hook 2
P682
A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formationYPEL3, a p53-regulated gene that induces cellular senescenceSIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activationmiR-543 and miR-590-3p regulate human mesenchymal stem cell aging via direct targeting of AIMP3/p18Cellular senescence induced by CD158d reprograms natural killer cells to promote vascular remodelingβ2-Microglobulin participates in development of lung emphysema by inducing lung epithelial cell senescence.Positive crosstalk between arginase-II and S6K1 in vascular endothelial inflammation and aging.
P921
Q14907028-03E66001-10D4-47BF-92A3-05133A30BDFBQ21101890-76616943-DBEE-436C-90D2-C9446C50093AQ21110969-0ADF6551-CD74-40AB-B809-5F09C4D65057Q21111778-54B702F1-C542-4CC0-B797-7BA8FB4D7320Q21113719-B36A5DFE-BDEF-4BF1-9615-717CFC0CF176Q21119913-A567B6FD-87B8-4908-9E5D-182A7E6C583CQ21133131-52D615DE-2B4E-4E63-8C91-FD5B85824951Q21136501-425A2D4B-60FE-4A45-B42F-5692C9F6A2C3Q21494203-C0256DBE-1CD4-42A3-B9DF-637D7C939BAFQ21495150-4F05EF52-1DA9-478F-9CDC-29FF753F19E5Q21498104-A62253C2-F6EF-419F-AF91-568E7E8D36CBQ21498354-42D975D0-D06F-438C-9626-64F97EA93D8FQ21499012-87853883-910B-43EC-9066-8EF713FCF84AQ21982331-0F550AD5-F2E5-450A-AF53-75FD35B0094DQ21982345-5C3098DB-D1C5-43F4-9330-782409EB0A44Q21984970-C041BE25-25B9-4BAB-8C8C-A37125141708Q21986122-6313D279-1BAB-48FC-822F-700C7DEF2748Q21986122-A9B67E08-88C5-4370-AFBA-3A0EC9262183Q21992308-286BE3DE-B3BA-4D26-8942-D193625EDC07Q22676633-195DA91A-0729-4A9A-8494-A3597023898DQ28559548-DA61BB96-23B1-4C29-ABAA-91B4A8D5ED88Q28559702-4CBA041A-4038-43B8-9D16-73B6E9DA718CQ29517585-C6107D62-7FFB-4189-BF0A-299BE6D5B4FFQ29520770-35E809A4-C84C-465C-87B6-D8F0BD52F96DQ29526763-E9D44FD0-1CCB-4C80-AC3C-D3360325CC32Q29529273-51AC4298-01F4-4D86-814C-9510AF6DC8F5Q3124896-35E60472-B449-476B-B5BA-B6EF34081B1BQ4042017-04F1E6CE-8D65-4240-9C86-84522F5E65B8Q416259-E81F83BC-41A6-44F9-A53F-14742BF64870Q55200099-5A018013-DA6B-4BF9-99A7-D1BAF84A56A5Q55204061-0144D8F4-88BE-462D-85CB-E30EC4A782F3Q5630986-686BB662-8E4B-4C51-8466-829D6D0112B6
P682
Q24299446-0E45D993-7556-4D43-BD43-434597BB6CEBQ24306557-D5DD331C-FDE2-49E0-B38E-E44FE70A074AQ24321658-EC5ED0B6-67E9-42F4-965E-7FE076C910A9Q28115122-350026E8-E4A5-4AAD-B594-88D30E985464Q36483484-7741F32B-9403-4B02-965B-F4225FAA8F03Q38954573-E2BD06FA-F8C6-48AE-9204-359661C6916BQ41412735-1285308F-6174-460D-88F2-311E27F5CD13
P921
description
Any process that activates or ...... extent of cellular senescence.
@en
biologisch proces
@nl
name
positive regulation of cellular senescence
@en
type
label
positive regulation of cellular senescence
@en
altLabel
GO:2000774
@en
prefLabel
positive regulation of cellular senescence
@en
P279
P279
P2888
P686
GO:2000774